CRH(CRH)
CRH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $39.74B | $41.80B | $44.53B | $47.68B | $50.62B |
| Low | $39.13B | $41.42B | $44.47B | $46.52B | $49.40B |
| High | $40.26B | $42.12B | $44.59B | $48.88B | $51.90B |
| EBITDA Avg | $9.57B | $10.06B | $10.72B | $11.48B | $12.19B |
| Low | $9.42B | $9.97B | $10.71B | $11.20B | $11.89B |
| High | $9.69B | $10.14B | $10.74B | $11.77B | $12.50B |
| EBIT Avg | $7.22B | $7.59B | $8.09B | $8.66B | $9.20B |
| Low | $7.11B | $7.52B | $8.08B | $8.45B | $8.97B |
| High | $7.31B | $7.65B | $8.10B | $8.88B | $9.43B |
| Net Income Avg | $3.98B | $4.48B | $5.01B | $5.99B | $6.65B |
| Low | $3.93B | $4.48B | $4.61B | $5.80B | $6.44B |
| High | $4.15B | $4.63B | $5.68B | $6.18B | $6.87B |
| EPS Avg | $5.94 | $6.69 | $7.48 | $8.84 | $9.83 |
| Low | $5.81 | $6.61 | $6.81 | $8.56 | $9.52 |
| High | $6.13 | $6.83 | $8.39 | $9.13 | $10.15 |
| Analysts (Rev / EPS) | 16 / 12 | 16 / 13 | 14 / 12 | 9 / 10 | 13 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $10.66B | $11.70B | $7.62B | $7.27B | $11.17B | $12.20B | $10.21B |
| Low | $10.60B | $11.54B | $7.32B | $7.17B | $10.84B | $12.03B | $9.91B |
| High | $10.72B | $11.91B | $7.76B | $7.40B | $11.32B | $12.41B | $10.35B |
| EBITDA Avg | $2.57B | $2.82B | $1.83B | $1.75B | $2.69B | $2.94B | $2.46B |
| Low | $2.55B | $2.78B | $1.76B | $1.73B | $2.61B | $2.90B | $2.39B |
| High | $2.58B | $2.87B | $1.87B | $1.78B | $2.73B | $2.99B | $2.49B |
| EBIT Avg | $1.94B | $2.13B | $1.38B | $1.32B | $2.03B | $2.22B | $1.86B |
| Low | $1.93B | $2.10B | $1.33B | $1.30B | $1.97B | $2.19B | $1.80B |
| High | $1.95B | $2.16B | $1.41B | $1.34B | $2.06B | $2.25B | $1.88B |
| Net Income Avg | $1.36B | $1.65B | $-86M | $-165M | $1.57B | $1.83B | $1.24B |
| Low | $1.32B | $1.62B | $-91M | $-169M | $1.51B | $1.80B | $1.19B |
| High | $1.39B | $1.69B | $-82M | $-162M | $1.59B | $1.88B | $1.26B |
| EPS Avg | $2.03 | $2.45 | $-0.13 | $-0.24 | $2.34 | $2.73 | $1.85 |
| Low | $1.97 | $2.41 | $-0.14 | $-0.25 | $2.25 | $2.68 | $1.78 |
| High | $2.08 | $2.51 | $-0.12 | $-0.24 | $2.38 | $2.79 | $1.88 |
| Analysts (Rev / EPS) | 5 / 4 | 2 / 1 | 7 / 5 | 2 / 2 | 3 / 1 | 2 / 1 | 3 / 1 |